Wearable technology has the potential to help people make more informed decisions about their healthcare, but what are the risks?

The landscape of modern healthcare is undergoing a profound shift from reactive treatments to proactive prevention, propelled by the unique pairing of artificial intelligence and consumer health insights.
We are already seeing the first chapters of this transformation unfold. Key examples include the launch of Claude for Healthcare and OpenAI’s strategic acquisition of the health data startup, Torch. AI is rapidly being embedded into the bedrock of preventative healthcare, fundamentally altering how we anticipate and manage wellness.
At its core, the true power of AI lies in its predictive capability – the power to forecast the exact steps a patient needs to take as early as possible to significantly improve their long-term health outcomes. In a perfect world, this technology will seamlessly foster a healthier global population. However, that promise hinges entirely on one critical caveat – the reliability of the data.
Protecting patients in the digital age
We are already living in the testing ground for this data-driven revolution. Wearable technology has transitioned from a niche fitness trend into a widespread medical ecosystem, with health tech devices and apps inundating us with daily metrics.
Statistics exist, though they should be taken with a note of caution, indicating that there are more than 500 million smartwatch users around the world, as of 2026. These smartwatches can now track a wide range of health indicators, including heart rate, breathing patterns, temperature and provide assessments of sleep quality, stress level, calories expended and blood oxygen levels.
AI health assistants such as Claude for Healthcare offer valuable insights for users. But safeguarding patient data requires transparency, robust independent oversight and accountability. There are already regulations in place, including the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, and the NHS in the UK, where completing paperwork, such as a Data Protection Impact Assessment, is necessary before integrating AI. But it’s clear that much more work is needed to build public confidence that data can be trusted and used appropriately.
Globally, there are stringent regulatory frameworks that govern access to pharmaceuticals and devices, as well as the processing and use of data. Ethics are at the heart of medical technologies, and the implications for patient safety in the era of artificial intelligence remain a core focus.
Biosensing and data analytics for enhanced public health outcomes
Advancements in sensing and wearable technologies – including smart watches and health monitoring apps – have driven a significant shift towards preventive healthcare, although they also place more responsibility on individuals. This has raised key questions: can these technologies make society healthier overall, and what are the risks? According to The Lancet Digital Health, there is strong evidence that wearables and activity trackers have contributed to a significant rise in physical activity among people of various ages and demographic groups.
Wearable technologies have boosted social interactions by becoming staples in fitness communities. Popular in settings such as park-runs and exercise classes, they have the potential to encourage and sustain healthy ageing across the population, yet they also carry significant drawbacks. Major risks associated with these devices have been widely discussed, including concerns about the sensitivity and security of personal data stored on them and who can access it, uncertainty over how commercial organisations or healthcare providers use this data, and frequent reports of these technologies intruding on daily life.
What’s more, these technologies can cause feelings of anxiety and other related conditions, resulting in counterproductivity or demotivation. Adding to this, the rise of artificial intelligence (AI) in these technologies presents new challenges. This brings us to another aspect of preventive healthcare – inclusive design principles and how we can ensure that everyone benefits from innovation.
Designing for everyone: the key to preventative healthcare
Preventative health measures can only truly benefit society and the economy if advanced, predictive technologies are accessible to everyone. To achieve a significant impact, these innovations cannot be limited to a privileged few. Instead, they must be intentionally designed to include individuals with diverse needs, ensuring that specific variations in vision, touch, comprehension or motion do not become barriers to usage.
To support this inclusive approach, the health data generated by these technologies must be fully accessible, easy to understand and robustly secure. Furthermore, the user experience should be highly customisable, adapting seamlessly to an individual’s unique physical condition and cultural background. Digital health tools must fit the user’s life, rather than forcing the user to adapt to rigid technology.
A critical step toward this goal is for manufacturers to integrate diverse societal communities into the engineering and design process from the very beginning. By including these perspectives in the initial research and development phases, companies can create products that resonate with a broader audience. Ultimately, this inclusive design strategy will encourage a much larger portion of the population to embrace preventative healthcare technologies, driving a profound improvement in overall public health.



© 2025, Lyonsdown Limited. Business Reporter® is a registered trademark of Lyonsdown Ltd. VAT registration number: 830519543